Janux Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.5M | 390k | 24.44 |
| 2025-06-30 | $6.8M | 293k | 23.10 |
| 2025-03-31 | $13M | 489k | 27.00 |
| 2024-12-31 | $12M | 225k | 53.54 |
| 2024-09-30 | $2.5M | 54k | 45.43 |
| 2024-06-30 | $2.1M | 51k | 41.89 |
| 2024-03-31 | $836k | 22k | 37.65 |
| 2023-03-31 | $10k | 841 | 12.10 |
| 2022-12-31 | $2.8k | 213 | 13.17 |
| 2022-03-31 | $50k | 3.5k | 14.29 |
| 2021-12-31 | $73k | 3.7k | 19.71 |
| 2021-09-30 | $76k | 3.5k | 21.71 |
| 2021-06-30 | $9.0k | 353 | 25.50 |